arrow
M

Maciej Pawłowski

Medical University Lodz
H指数:30
被引数:3,151

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties
2021-09-0110
OAAI
2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity

2-苯基-1h-吡咯-3-甲酰胺作为开发具有认知增强活性的5-HT6受体反向激动剂的新支架

2021-03-1112
OAAI
Discovery of Novel pERK1/2-or β-Arrestin-Preferring 5-HT1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile
2020-09-0423
OAAI
Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD)
2020-04-019
OAAI
Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT1A Receptor-Biased Agonists with Robust Antidepressant-like Activity
2019-02-0525
OAAI
Characteristics of metabolic stability and the cell permeability of 2-pyrimidinyl-piperazinyl-alkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione with antidepressant- and anxiolytic-like activities
2018-12-0410
PREAI
Novel butanehydrazide derivatives of purine-2,6-dione as dual PDE4/7 inhibitors with potential anti-inflammatory activity: Design, synthesis and biological evaluation

具有潜在抗炎活性的嘌呤-2,6-二酮的新型丁酰肼衍生物作为双重PDE4/7抑制剂: 设计,合成和生物学评估

2018-02-0137
PREAI